Jeremy Berg has a new President’s Message up at ASBMB Today. It looks into a topic of substantial interest to me, i.e., the fate of investigators funded by the NIH. This contrasts with our more-usual focus on the fate of applications.
With that said, the analysis does place the impact of the sequester in relatively sharp focus: There were about a thousand fewer investigators funded by these mechanisms in FY13 compared with FY12. This represents more than six times the number of investigators who lost this funding from FY11 to FY12 and a 3.8 percent drop in the R-mechanism-funded investigator cohort.
another tidbit addresses the usual claim from NIHlandia that R-mechs and R01s in particular are always prioritized.
In her post, Rockey notes that the total funding for all research project grants, or RPGs, dropped from $15.92 billion in FY12 to $14.92 billion in FY13, a decrease of 6.3 percent. The total funding going to the R series awards that I examined (which makes up about 85 percent of the RPG pool) dropped by 8.9 percent.
What accounts for this difference? U01 awards comprise the largest remaining portion of the RPG pool…The funds devoted to U01 awards remained essentially constant from FY12 to FY13 at $1.57 billion.
Go Read the whole thing.
This type of analysis really needs more attention at the NIH level. They’ve come a looooong way in recent years in terms of their willingness to focus on what they are actually doing in terms of applications, funding, etc. This is in no small part due to the efforts of Jeremy Berg, who used to be the Director of NIGMS. But tracking the fate of applications only goes so far, particularly when it is assessed only on a 1-2 year basis.
The demand on the NIH budget is related to the pool of PIs seeking funding. This pool is considerably less elastic than the submission of grant applications. PIs don’t submit grant applications endlessly for fun, you know. They seek a certain level of funding. Once they reach that, they tend to stop submitting applications. A lot of the increase in application churn over the past decade or so has to do with the relative stability of funding. When odds of continuing an ongoing project are high, a large number of PIs can just submit one or two apps every 5 years and all is well. Uncertainty is what makes her submit each and every year.
Similarly, when a PI is out of funding completely, the number of applications from this lab will rise dramatically….right up until one of them hits.
I argue that if solutions to the application churn and the funding uncertainty (which decreases overall productivity of the NIH enterprise) are to be found, they will depend on a clear understanding of the dynamics of the PI population.
Berg has identified two years in which the PI turnover is very different. How do these numbers compare with historical trends? Which is the unusual one? Or is this the expected range?
Can we see the 1,000 PI loss as a temporary situation or a permanent fix? It is an open question as to how many sequential years without NIH funding will affect the PI. Do these individuals tend to regain funding in 2, 3 or 4 years’ time? Do they tend to go away and never come back? More usefully, what proportion of the lost investigators will follow these fates?
The same questions arise for the other factoids Berg mentions. The R00 transition to other funding would seem to be incredibly important to know. But a one year gap seems hardly worth discussing. This can easily happen under the current conditions. But if they are not getting funded after 2 or maybe 3 years after the R00 expires? This is of greater impact.
Still, a welcome first step, Dr. Berg. Let’s hope Sally Rockey is listening.